uveal
inflamm
result
varieti
caus
trauma
infect
neoplasia
immunemedi
diseas
case
uveiti
inflammatori
reaction
known
primari
caus
therefor
suspect
autoimmun
diseas
uveiti
one
import
group
ocular
diseas
cat
may
first
indic
seriou
lifethreaten
system
diseas
small
size
close
proxim
intraocular
structur
make
earli
recognit
treatment
uveiti
imper
avoid
sightthreaten
consequ
anterior
uveiti
iridocycl
involv
inflamm
iri
ciliari
bodi
although
iriti
impli
inflamm
iri
often
use
synonym
anterior
uveiti
intermedi
uveiti
also
refer
par
planiti
involv
predominantli
posterior
portion
ciliari
bodi
par
plana
strictli
speak
posterior
uveiti
inflamm
choroid
choroid
retina
usual
affect
concurr
chorioretin
accur
term
anterior
posterior
uveal
tissu
part
continuum
inflamm
commonli
occur
simultan
panuv
term
use
entir
uveal
tract
inflam
mani
exogen
endogen
caus
uveiti
exist
cat
exogen
caus
trauma
eye
includ
blunt
penetr
surgic
trauma
may
may
includ
infect
corneal
ulcer
endogen
uveiti
may
parasit
infecti
neoplast
immunemedi
idiopath
infecti
agent
associ
develop
uveiti
cat
found
tabl
per
cent
case
uveiti
cat
report
associ
clinic
serolog
evid
infecti
diseas
common
infecti
diseas
associ
uveiti
toxoplasmosi
felin
infecti
periton
fip
felin
immunodefici
viru
fiv
felin
leukemia
viru
felv
tissu
intraocular
inflamm
initi
local
tissu
injuri
eg
trauma
infecti
agent
antigen
challeng
tissu
factor
chemoattract
releas
damag
tissu
microorgan
vasodil
chang
vascular
permeabl
follow
chang
indic
disrupt
bloodocular
barrier
inflammatori
mediat
releas
damag
tissu
cell
caus
leukocyt
activ
migrat
globe
lymphat
drainag
antigen
degrad
organ
transport
spleen
lymphoid
tissu
via
venou
system
activ
antigenspecif
b
lymphocyt
immunocompet
b
lymphocyt
migrat
back
eye
resid
uvea
factor
believ
help
stop
immun
respons
includ
elimin
incit
antigen
product
inhibitori
cytokin
b
lymphocyt
incit
antigen
remov
complet
autoimmun
diseas
chronic
inflamm
result
propos
mechan
contribut
develop
autoimmun
uveiti
includ
abnorm
induct
toler
autoantigen
releas
normal
sequest
autoantigen
result
trauma
infect
molecular
mimicri
homolog
pathogen
host
tissu
antigen
alter
autoantigen
structur
result
tissu
injuri
inflamm
uvea
contain
immunocompet
lymphocyt
chronic
recurr
inflamm
also
could
result
specif
nonspecif
activ
lymphocyt
nonself
antigen
clinician
must
impress
upon
client
even
exhaust
diagnost
evalu
specif
caus
uveiti
may
found
client
understand
regardless
incit
caus
uveiti
may
becom
chronic
treatment
may
palli
advers
sequela
common
variat
clinic
appear
uveiti
depend
locat
durat
sever
ocular
pain
manifest
photophobia
blepharospasm
enophthalmo
elev
third
eyelid
andor
epiphora
common
acut
anterior
uveiti
may
absent
chronic
redden
sclera
caus
inject
conjunctiv
episcler
vessel
aqueou
flare
hallmark
anterior
uveiti
aqueou
flare
caus
increas
protein
concentr
aqueou
humor
secondari
disrupt
bloodocular
barrier
light
pass
anterior
chamber
scatter
aqueou
flare
sever
aqueou
humor
appear
cloudi
corneal
edema
result
effect
inflamm
corneal
endothelium
edema
increas
cornea
becom
increasingli
opaqu
blue
inflammatori
cell
aqueou
humor
may
deposit
intern
surfac
corneal
endothelium
kerat
precipit
kp
normal
convect
current
aqueou
humor
caus
kp
locat
primarili
ventral
half
cornea
kerat
precipit
vari
size
larger
kp
seen
often
granulomat
inflammatori
process
associ
diseas
fip
toxoplasmosi
figur
iri
undergo
mani
chang
anterior
uveiti
inflammatori
mediat
particular
prostaglandin
caus
miosi
direct
effect
iri
sphincter
mild
miosi
difficult
detect
absenc
use
rule
uveiti
iriti
manifest
iri
vasodil
increas
iri
vessel
permeabl
often
caus
subtl
pronounc
iri
color
chang
close
examin
dilat
iri
vessel
may
obviou
iri
may
appear
swollen
thin
coat
fibrin
cell
give
velvetlik
textur
anterior
uveiti
becom
chronic
pupil
margin
may
begin
form
posterior
synechia
adhes
anterior
len
capsul
give
pupil
irregular
shape
impair
abil
respond
light
dilat
agent
figur
extens
posterior
synechia
develop
aqueou
humor
move
posterior
chamber
anterior
chamber
aqueou
humor
accumul
behind
iri
caus
billow
forward
condit
known
iri
access
anterior
chamber
requir
aqueou
humor
reach
filtrat
angl
iri
associ
increas
intraocular
pressur
glaucoma
peripher
anterior
synechia
adhes
peripher
iri
cornea
form
anterior
uveiti
result
iri
secondari
iri
swell
inflamm
inflammatori
cell
iri
swell
anterior
synechia
also
impair
aqueou
outflow
contribut
develop
secondari
glaucoma
aqueou
humor
format
impair
ciliari
bodi
inflam
thu
anterior
uveiti
caus
low
intraocular
pressur
unless
complic
secondari
glaucoma
inflamm
also
caus
ciliari
muscl
spasm
major
contributor
ocular
pain
accumul
inflammatori
cell
peripher
anterior
vitreou
refer
par
planiti
intermedi
uveiti
peripher
locat
par
planiti
often
appar
without
dilat
pupil
posterior
uveiti
inflamm
posterior
uvea
choroid
close
apposit
retin
inflamm
often
accompani
inflamm
choroid
creat
chorioretin
chang
ocular
fundu
secondari
chorioretin
relat
breakdown
bloodocular
barrier
locat
retin
blood
vessel
retin
pigment
epithelium
increas
permeabl
barrier
allow
compon
blood
accumul
within
choroid
retina
migrat
inflammatori
cell
area
inflamm
also
occur
clinic
retin
subretin
fluid
exud
hemorrhag
detect
retina
subretin
space
overli
tapetum
tapet
reflect
diminish
obscur
area
activ
chorioretin
figur
sever
chorioretin
lead
partial
complet
retin
detach
decreas
vision
blind
inflamm
anterior
posterior
uvea
term
endophthalm
connect
uveiti
infecti
diseas
difficult
make
caus
uveiti
gener
differenti
clinic
appear
addit
complet
physic
examin
complet
blood
count
urinalysi
serum
biochem
panel
addit
ancillari
diagnost
test
serolog
aqueou
vitreou
humor
analysi
histopatholog
often
need
arriv
specif
diagnosi
ocular
fluid
use
cytolog
cultur
sensit
polymeras
chain
reaction
determin
antibodi
content
gener
anesthesia
recommend
anterior
chamber
paracentesi
perform
paracentesi
needl
syring
small
rattooth
forcep
adequ
light
magnif
need
bulbar
conjunctiva
cornea
flush
gentli
povidoneiodin
steril
salin
solut
povidoneiodin
soap
use
irrit
cornea
conjunctiva
globe
grasp
forcep
dorsolater
limbu
needl
enter
eye
limbu
parallel
iri
plane
globe
stabl
needl
enter
eye
immedi
adjac
hold
forcep
care
taken
keep
needl
bevel
tip
away
iri
len
figur
ml
aqueou
humor
usual
remov
slowli
without
collaps
anterior
chamber
withdraw
needl
gentl
pressur
appli
centesi
site
use
moisten
cotton
swab
sampl
aqueou
humor
drop
directli
onto
swab
cultur
sensit
store
steril
contain
red
top
tube
antigen
dna
antibodi
measur
techniqu
cytolog
examin
best
perform
sampl
store
blood
collect
tube
contain
ethylenediaminetetraacet
acid
edta
concentr
centrifug
stain
difquick
wright
stain
substrat
requir
pcr
real
timepcr
rtpcr
assay
vari
assay
mani
perform
frozen
sampl
clinician
contact
appropri
laboratori
transport
instruct
indic
aqueou
humor
paracentesi
found
tabl
mild
hyphema
common
complic
aqueou
humor
paracentesi
seriou
complic
rare
care
taken
avoid
inadvert
contact
iri
len
vitreou
paracentesi
consid
method
diagnosi
unreward
larg
vitreou
mass
subretin
exud
found
ophthalmoscopi
ultrasonographi
howev
vitreou
paracentesi
gener
reserv
blind
nearli
blind
eye
potenti
caus
sever
ocular
hemorrhag
retin
tear
retin
detach
gener
anesthesia
recommend
aspir
bulbar
conjunctiva
clean
gentli
povidoneiodin
steril
salin
solut
remov
mucu
debri
dorsolater
globe
grasp
mm
behind
limbu
small
tooth
forcep
vitreou
viscou
difficult
aspir
syring
need
adequ
suction
aspir
needl
attempt
first
needl
often
need
obtain
suffici
sampl
analysi
needl
aim
toward
center
globe
introduc
eye
mm
posterior
limbu
adjac
forcep
maxim
stabil
figur
mass
present
needl
guid
ultrasound
mass
aspir
ocular
media
clear
needl
guid
visual
use
indirect
ophthalmoscopi
care
taken
advanc
needl
opposit
retina
choroid
slightli
alter
needl
posit
may
help
aspir
fluid
difficult
bacteri
endophthalm
suspect
vitreou
inject
antibiot
plan
syring
remov
needl
left
place
inject
vitreou
sampl
handl
aqueou
humor
sampl
cultur
cytolog
pcr
assay
rtpcr
assay
see
tabl
primari
treatment
goal
uveiti
stop
inflamm
prevent
control
complic
caus
inflamm
reliev
pain
specif
nonspecif
therapi
involv
treatment
uveiti
specif
therapi
use
infecti
agent
eg
bacteria
protozoan
fungi
contributor
inflamm
eg
foreign
bodi
corneal
ulcer
luxat
len
identifi
examin
diagnost
evalu
nonspecif
therapi
includ
decreas
ocular
inflammatori
respons
antiinflammatori
drug
mydriasi
prevent
synechia
format
cycloplegia
decreas
pain
glaucoma
therapi
also
institut
evid
exist
decreas
aqueou
humor
outflow
therapi
specif
agent
caus
uveiti
discuss
individu
head
antiinflammatori
therapi
critic
treatment
uveiti
regardless
caus
failur
control
inflamm
lead
posterior
synechia
glaucoma
cataract
retin
detach
vitreou
degener
optic
nerv
atrophi
retin
degener
glucocorticoid
nonsteroid
antiinflammatori
drug
nsaid
use
commonli
control
inflamm
glucocorticoid
gc
administ
topic
subconjunctiv
system
anterior
uveiti
usual
treat
topic
minimum
everi
hour
frequent
everi
hour
depend
sever
inflamm
aggress
treatment
continu
inflamm
control
frequenc
administr
taper
slowli
inflamm
control
frequent
treatment
possibl
supplement
oral
gc
consid
topic
prepar
best
potenc
corneal
penetr
prednisolon
acet
suspens
per
cent
dexamethason
solut
per
cent
ointment
per
cent
topic
gc
contraind
presenc
corneal
ulcer
inhibit
wound
heal
augment
collagenas
activ
cornea
system
administr
gc
minim
corneal
effect
unless
cornea
heavili
vascular
therefor
administ
concurr
corneal
ulcer
anterior
uveiti
exist
ocular
releas
prostaglandin
caus
disrupt
bloodocular
barrier
uveiti
nsaid
decreas
inflamm
inhibit
cyclooxygenas
result
decreas
product
prostaglandin
nsaid
unlik
gc
inhibit
lipoxygenas
inflammatori
pathway
littl
inform
exist
regard
use
treatment
uveit
cat
therefor
use
nsaid
consid
primarili
gc
contraind
frequent
use
topic
ophthalm
nsaid
includ
diclofenac
per
cent
flurbiprofen
per
cent
suprofen
per
cent
ketorolac
per
cent
ocular
hemorrhag
caus
platelet
aggreg
inhibit
potenti
complic
use
topic
nsaid
may
complic
bacteri
corneal
infect
recommend
corneal
infect
present
system
drug
therapi
necessari
treat
posterior
uveiti
therapeut
concentr
attain
retina
choroid
topic
drug
gc
suppress
immun
respons
use
caution
infect
suspect
especi
given
system
use
infect
concurr
treatment
effect
antimicrobi
essenti
drug
dosag
rout
gc
administr
found
tabl
use
system
nsaid
cat
associ
potenti
seriou
side
effect
includ
bone
marrow
suppress
gastrointestin
ulcer
hemorrhag
vomit
diarrhea
aspirin
phenylbutazon
ketoprofen
meloxicam
use
system
cat
care
attent
dose
frequenc
administr
possibl
side
effect
cours
phenylbutazon
therapi
kept
short
possibl
prefer
exceed
day
higher
dosag
drug
withheld
inappet
depress
develop
duoden
perfor
cat
follow
treatment
oral
carprofen
report
report
indic
carprofen
administ
safe
cat
postop
analges
subconjunctiv
gc
use
supplement
topic
system
gc
therapi
case
sever
ocular
inflamm
patient
frequent
topic
treatment
possibl
subconjunctiv
prepar
use
longact
give
constant
sourc
drug
releas
period
disadvantag
use
inabl
withdraw
medic
complic
aris
drug
inject
subconjunctiv
enter
eye
cornea
leakag
inject
site
sclera
subconjunctiv
gc
contraind
activ
corneal
ulcer
topic
subconjunctiv
gc
use
also
may
result
reactiv
felin
carrier
cat
previou
episod
viral
kerat
conjunct
administr
subconjunctiv
gc
cat
suspect
recurr
felin
herpesviru
ocular
diseas
recommend
cyclopleg
reliev
pain
associ
anterior
uveiti
relax
ciliari
bodi
iri
muscl
spasm
mydriat
prevent
break
posterior
synechia
dilat
pupil
reduct
irislen
contact
cycloplegia
mydriasi
accomplish
use
parasympatholyt
agent
topic
per
cent
atropin
sulfat
ointment
use
commonli
ocular
solut
like
reach
mouth
via
nasolacrim
duct
caus
profus
saliv
result
bitter
tast
durat
frequenc
applic
depend
sever
ocular
inflamm
mild
inflamm
usual
treat
daili
sever
inflamm
may
requir
treatment
three
four
time
daili
maintain
iri
dilat
parasympatholyt
caus
decreas
tear
product
gener
appli
pupil
dilat
discontinu
pupil
begin
constrict
addit
sympathomimet
agent
may
help
achiev
mydriasi
synechia
form
alreadi
see
tabl
serolog
evid
infect
toxoplasma
gondii
report
mani
per
cent
cat
anterior
andor
posterior
uveiti
ocular
lesion
toxoplasmosi
welldocu
uniqu
ophthalmolog
find
associ
gondii
infect
cat
often
becom
infect
carnivor
histori
ingest
undercook
meat
hunt
activ
common
acut
polysystem
ill
associ
toxoplasmosi
uncommon
fever
hyperesthesia
possibl
relat
muscl
inflamm
common
system
sign
actual
preval
ocular
toxoplasmosi
unknown
mani
cat
uveiti
posit
gondii
serolog
clinic
evid
diseas
avail
ocular
histopatholog
case
rare
identifi
organ
make
difficult
correl
posit
serolog
ocular
infect
especi
true
mani
commerci
laboratori
test
detect
gondii
antibodi
product
aqueou
humor
also
use
support
diagnosi
ocular
toxoplasmosi
cat
test
use
enzymelink
immunosorb
assay
elisa
detect
antibodi
gondii
serum
aqueou
humor
goldmanwitm
coeffici
cvalu
calcul
adjust
antibodi
leakag
serum
cvalu
greater
indic
gondiispecif
antibodi
produc
eye
igm
product
detect
aqueou
humor
cat
uveiti
detect
igm
might
indic
diseas
result
organ
toxoplasma
gondii
dna
amplifi
blood
aqueou
humor
use
pcr
assay
howev
posit
result
found
appar
healthi
research
cat
posit
predict
valu
per
cent
although
definit
diagnosi
ocular
toxoplasmosi
difficult
make
confirm
treatment
antitoxoplasma
drug
justifi
caus
uveiti
rule
serolog
evid
exist
recent
activ
infect
ocular
gondii
antibodi
product
particularli
igm
identifi
organism
dna
found
aqueou
humor
mani
cat
uveiti
seroposit
gondii
otherwis
clinic
healthi
cat
anterior
uveiti
topic
treatment
per
cent
atropin
effect
per
cent
prednisolon
acet
per
cent
dexamethason
indic
frequenc
gc
treatment
vari
depend
sever
clinic
sign
gener
minim
respons
poor
uveiti
sever
frequent
administr
topic
gc
need
possibl
oral
administr
prednisolon
usual
given
safe
antiinflammatori
dosag
without
signific
risk
potenti
system
toxoplasmosi
inflamm
subsid
treatment
taper
slowli
gc
taper
quickli
discontinu
soon
inflamm
recur
author
recommend
aggress
treatment
uveiti
resolv
oral
gc
usual
taper
first
follow
topic
system
ill
gondiiseroposit
cat
alway
treat
antitoxoplasma
drug
cat
uveiti
alon
treatment
antitoxoplasma
drug
justifi
gondiiseroposit
cat
uveiti
caus
uveiti
rule
particularli
gc
therapi
elicit
respons
clindamycin
drug
choic
treat
clinic
toxoplasmosi
cat
although
sever
dose
rang
report
author
current
recommend
mgkg
po
week
liquid
clindamycin
administ
c
toler
cat
trimethoprimsulfonamid
combin
therapi
mgkg
po
week
also
use
treatment
toxoplasmosi
although
less
suitabl
potenti
side
effect
caus
folic
acid
defici
cat
frequent
monitor
mental
depress
anemia
leukopenia
thrombocytopenia
requir
especi
treatment
longer
week
azithromycin
potenti
altern
choic
cat
intoler
clindamycin
sulfa
drug
howev
appropri
dose
treatment
toxoplasmosi
determin
nonspecif
treatment
uveiti
use
concurr
date
evid
suggest
use
topic
corticosteroid
exacerb
system
toxoplasmosi
mani
cat
fip
younger
year
old
develop
clinic
sign
system
coronaviru
diseas
ocular
diseas
accompani
ascit
thorac
pericardi
effus
depress
icteru
renal
failur
diarrhea
neurolog
sign
suggest
fip
ocular
lesion
seen
often
noneffus
dri
form
fip
anterior
andor
posterior
uveiti
may
present
iriti
larg
kerat
precipit
clot
fibrin
blood
anterior
chamber
found
commonli
along
cuf
retin
vasculatur
chorioretin
similar
toxoplasmosi
confirm
diagnosi
fip
challeng
studi
shown
per
cent
household
pet
per
cent
catteryrear
cat
carri
serum
antibodi
felin
coronaviru
current
serodiagnost
test
distinguish
antibodi
pathogen
nonpathogen
coronavirus
therefor
diagnosi
usual
base
combin
clinic
sign
physic
examin
find
laboratori
evalu
high
serum
globulin
gdl
low
albumin
globulin
ratio
effus
total
protein
content
greater
gdl
also
support
although
high
coronaviru
antibodi
titer
also
support
correl
diseas
well
hyperglobulinemia
low
albumin
globulin
ratio
rtpcr
test
blood
use
diagnosi
fip
nonpathogen
coronavirus
found
serum
plasma
normal
cat
detect
coronaviru
rna
tissu
effus
aqueou
humor
rtpcr
assay
may
correl
presenc
fip
howev
nonpathogen
coronaviru
also
found
tissu
normal
cat
longterm
prognosi
fip
poor
even
treatment
howev
patient
ocular
diseas
may
manag
reason
sever
month
year
medic
therapi
diseas
gener
pathogenesi
diseas
fip
immun
mediat
primari
goal
treatment
suppress
immun
respons
sever
protocol
describ
current
consensu
exist
regard
optim
treatment
system
diseas
ocular
fip
control
inflamm
prevent
sequela
goal
treatment
uveiti
caus
fip
system
topic
gc
may
requir
see
nonspecif
therapi
uveiti
felvassoci
diseas
detect
often
young
cat
ocular
diseas
occur
alon
combin
system
sign
ill
ocular
diseas
occur
felv
infect
except
associ
develop
lymphosarcoma
lsa
immun
suppress
increas
suscept
infecti
diseas
gondii
system
mycos
incid
ocular
diseas
among
clinic
affect
felvposit
cat
report
low
per
cent
less
howev
lsa
shown
common
caus
uveiti
enucl
eye
ocular
lesion
lsa
result
neoplast
infiltr
uveal
tract
clinic
sign
depend
tumor
distribut
nodular
diffus
infiltr
anterior
andor
posterior
uveal
tract
possibl
diffus
appear
similar
uveiti
result
caus
although
isol
ocular
lsa
probabl
occur
ocular
diseas
may
primari
clinic
sign
mani
cat
ocular
lsa
appear
clinic
healthi
otherwis
confirm
diagnosi
ocular
lsa
requir
identif
neoplast
lymphocyt
sometim
found
aqueou
humor
cytolog
usual
bone
marrow
cytolog
biopsi
tumor
locat
elsewher
bodi
necessari
test
infect
felv
alway
indic
treatment
prognosi
may
alter
felv
statu
howev
use
felv
test
diagnost
purpos
limit
felvposit
cat
lsa
convers
neg
felv
test
rule
lsa
per
cent
cat
confirm
lsa
felvneg
elisa
detect
antigen
blood
wide
use
commerci
avail
screen
test
felv
pcr
assay
use
confirm
lymphoma
evalu
use
dog
data
collect
concern
use
cat
cat
lsa
stage
felv
statu
determin
relat
treatment
respons
prognosi
mani
chemotherapeut
drug
use
treat
lsa
cat
excel
review
drug
administr
protocol
found
literatur
ancillari
therapi
topic
gc
atropin
help
control
ocular
inflamm
prevent
sequela
see
nonspecif
therapi
uveiti
system
gc
use
caution
effect
viral
replic
known
blind
pain
eye
may
requir
enucl
immunosuppress
induc
viru
consid
part
clinic
syndrom
use
immunomodul
therapi
antivir
therapi
consid
administr
interferon
alpha
ucat
po
seem
improv
qualiti
life
cat
affect
viremia
protocol
assess
control
studi
ocular
diseas
associ
felv
antivir
therapi
consid
azidothymidin
azt
administ
describ
fiv
may
lessen
risk
secondari
infect
assess
control
studi
treat
ocular
manifest
felv
clinic
diseas
fivinfect
cat
usual
detect
older
male
cat
histori
exposur
cat
histori
fight
clinic
ill
often
associ
immunodefici
result
secondari
infect
sever
primari
diseas
syndrom
attribut
viru
includ
uveiti
enter
renal
diseas
histopatholog
evid
anterior
uveiti
found
commonli
cat
advanc
fiv
infect
confirm
viru
primari
caus
uveiti
local
product
fiv
antibodi
antigen
aqueou
humor
document
recent
fivinfect
cat
uveiti
healthi
fivseroposit
cat
result
support
hypothesi
fiv
activ
infect
eye
cat
produc
uveiti
toxoplasma
gondii
bartonella
hensela
cryptococcu
neoforman
infect
detect
concurr
fivseroposit
cat
suggest
may
common
opportunist
infect
clinic
anterior
uveiti
par
planiti
glaucoma
without
concurr
uveiti
identifi
cat
infect
fiv
par
planiti
appear
white
punctat
infiltr
concentr
peripher
anterior
vitreou
present
avail
commerci
pcr
test
fiv
suffici
reliabl
recommend
use
confirm
rule
fiv
infect
serum
antibodi
fiv
detect
elisa
western
blot
immunoassay
immunofluoresc
antibodi
test
organ
detect
blood
pcr
viru
isol
elisa
test
use
frequent
avail
inclin
use
fiv
clear
immun
respons
posit
antibodi
test
gener
indic
current
infect
elisa
test
occasion
produc
falseposit
result
posit
test
confirm
western
blot
immunoassay
addit
confound
factor
antibodi
induc
commerci
avail
fiv
vaccin
felovax
fort
dodg
laboratori
distinguish
induc
natur
infect
present
avail
fiv
antibodi
test
vaccin
statu
cat
uveiti
must
determin
detect
fiv
antibodi
prove
uveiti
due
fiv
mani
fivseroposit
cat
uveiti
serolog
evid
exposur
pathogen
caus
uveiti
opportunist
infect
exclud
list
differenti
diagnos
uveiti
attribut
sole
fiv
treatment
fiv
aim
primarili
manag
secondari
infect
identifi
howev
ocular
inflamm
anterior
uveiti
par
planiti
also
direct
result
viru
azt
may
improv
qualiti
life
prolong
life
expect
cat
fiv
infect
given
mgkg
po
azt
toler
cat
minim
toxic
howev
efficaci
azt
treatment
ocular
diseas
induc
fiv
current
unknown
topic
gc
atropin
therapi
use
control
pain
inflamm
discuss
previous
felvinfect
cat
system
gc
use
caution
effect
viral
replic
known
ocular
diseas
report
cat
result
dissemin
histoplasmosi
blastomycosi
coccidioidomycosi
cryptococcosi
rare
candidiasi
cryptococcosi
common
system
mycos
seen
cat
usual
associ
nasal
caviti
diseas
cutan
involv
especi
nasal
region
neurolog
sign
also
common
intraocular
manifest
system
mycos
includ
chorioretin
anterior
uveiti
although
chorioretin
alon
common
figur
definit
diagnosi
made
demonstr
organ
csf
vitreou
aqueou
humor
cytolog
nasal
exud
aspir
lymph
node
tissu
cultur
tissu
biopsi
histopatholog
may
necessari
confirm
diagnosi
case
c
neoforman
antigen
test
latex
agglutin
elisa
avail
use
serum
aqueou
humor
vitreou
humor
superior
antibodi
test
posit
test
result
confirm
presenc
organ
bodi
even
organ
identifi
cytolog
histolog
cultur
serum
antigen
test
perform
serv
baselin
therapeut
monitor
detect
antibodi
coccidioid
immiti
blastomyc
dermatitidi
may
use
aid
diagnosi
organ
found
falseposit
falseneg
result
may
occur
serolog
test
histoplasma
capsulatum
unreli
cat
ketoconazol
ktz
itraconazol
itz
fluconazol
ftz
drug
use
often
treatment
cryptococc
infect
cat
ftz
fewest
side
effect
penetr
cn
better
ktz
itz
ftz
itz
toler
cat
empir
dose
mgcat
po
treatment
antifung
agent
continu
least
month
resolut
clinic
sign
cryptococc
antigen
titer
drop
least
two
order
magnitud
present
anterior
uveiti
treat
topic
gc
per
cent
prednisolon
acet
atropin
treatment
chorioretin
optic
neuriti
requir
system
drug
therapi
extrem
judici
use
oral
gc
along
antifung
therapi
may
necessari
control
inflamm
associ
posterior
segment
infect
eye
sever
posterior
segment
infect
respond
antifung
medic
may
requir
enucl
b
hensela
bartonella
clarridgeia
two
caus
catscratch
diseas
human
be
uveal
tract
inflamm
b
hensela
infect
peopl
report
cat
appar
reservoir
host
b
hensela
per
cent
cat
b
henselaeseroposit
flea
transmit
organ
incid
infect
highest
area
warm
humid
climat
highli
endem
ctenocephalid
feli
major
natur
infect
experiment
infect
cat
show
clinic
evid
diseas
transient
fever
lymphadenopathi
stomat
neurolog
sign
report
see
chapter
bartonella
spp
suggest
like
caus
anterior
uveiti
one
cat
base
presenc
bartonella
spp
antibodi
product
aqueou
humor
clinic
respons
doxycyclin
bartonella
spp
aqueou
antibodi
product
evid
seven
cat
uveiti
zero
healthi
cat
anoth
studi
studi
three
cat
uveiti
one
healthi
cat
bartonella
spp
dna
aqueou
humor
detect
pcr
result
suggest
organ
invad
eye
cat
may
associ
uveiti
cat
cultur
pcr
assay
result
use
confirm
bartonella
spp
infect
cat
howev
mani
healthi
cat
seroposit
pcr
assay
posit
cultureposit
whole
blood
test
use
prove
ocular
bartonellosi
bartonella
spp
resid
within
red
blood
cell
hyphema
often
accompani
uveiti
detect
organ
aqueou
humor
may
indic
bleed
eye
inform
concern
diagnost
util
aqueou
humor
test
need
bartonella
spp
consid
list
differenti
diagnos
cat
uveiti
without
known
caus
particularli
gc
therapi
ineffect
histori
flea
infest
exist
patient
fit
criteria
may
prudent
administ
drug
antibartonella
activ
doxycyclin
effect
given
mgkg
one
cat
howev
dosag
mgkg
po
week
recommend
recent
lower
dosag
shown
ineffect
elimin
bacteremia
enrofloxacin
mgcat
po
altern
protocol
unrespons
cat
cat
intoler
tetracyclin
lastli
azithromycin
mgkg
po
may
effect
studi
treatment
bartonellaassoci
ocular
diseas
cat
topic
nonspecif
therapi
use
concurr
treat
uveiti
felin
tuberculosi
tb
caus
commonli
ingest
uncook
meat
unpasteur
milk
cattl
infect
mycobacterium
bovi
erad
measur
preval
bovin
tb
thu
felin
tb
rare
unit
state
chronic
anterior
uveiti
granulomat
chorioretin
ocular
hemorrhag
retin
detach
may
found
case
felin
tuberculosi
clinic
sign
reflect
site
primari
infect
often
gastrointestin
diagnosi
made
identif
acidfast
bacilli
tissu
aspir
biopsi
specimen
intraderm
skin
test
serolog
test
unreli
cat
commerci
avail
pcr
test
like
avail
near
futur
although
cat
bovi
infect
treat
success
oral
rifampin
mgkgday
month
excis
skin
lesion
whether
treat
seriou
concern
human
health
hazard
potenti
develop
drug
resist
intraocular
parasit
migrat
ophthalmomyiasi
uncommon
caus
ocular
diseas
cat
case
caus
larval
stage
rabbit
rodent
bot
fli
cuterebra
spp
although
intraocular
migrat
adult
nematod
also
report
anterior
chamber
involv
caus
acut
sever
anterior
segment
inflamm
often
poorli
respons
medic
therapi
retin
degener
unknown
mechan
may
sequela
anterior
segment
cuterebra
spp
migrat
posterior
segment
parasit
migrat
caus
minim
inflamm
confin
subretin
space
diagnosi
made
observ
parasit
observ
typic
curvilinear
subretin
migrat
tract
possibl
parasit
remov
surgic
follow
aggress
medic
manag
uveiti
herpesviru
infect
peopl
associ
commonli
uveiti
recent
felin
believ
caus
conjunct
kerat
serum
aqueou
humor
collect
healthi
cat
cat
idiopath
uveiti
cat
suspect
toxoplasma
spp
uveiti
antibodi
measur
serum
aqueou
humor
dna
measur
aqueou
humor
pcr
assay
local
product
antibodi
detect
frequent
cat
uveiti
c
valu
greater
detect
cat
idiopath
uveiti
addit
herpesviru
dna
detect
aqueou
humor
cat
uveiti
one
healthi
cat
result
show
enter
eye
cat
may
associ
uveiti
major
clientown
cat
vaccin
preexpos
antibodi
detect
sera
thu
serum
antibodi
detect
benefit
diagnosi
uveiti
data
need
treatment
recommend
made
ehrlichia
spp
gramneg
rickettsia
infect
wide
varieti
host
usual
tickborn
ehrlichia
spp
infect
detect
dog
uveal
tract
inflamm
world
literatur
contain
report
small
number
cat
ehrlichiosi
clinic
syndrom
report
includ
uveiti
otherwis
similar
dog
epidemiolog
studi
compar
incid
clinic
sign
cat
without
ehrlichia
spp
serum
antibodi
statist
associ
made
ocular
discharg
uveiti
work
requir
elucid
involv
ehrlichia
spp
infect
cat
uveiti
aggress
treatment
uveiti
necessari
avoid
secondari
sightthreaten
complic
format
synechia
lead
glaucoma
obstruct
flow
aqueou
humor
pupil
andor
iridocorn
angl
intraocular
pressur
iop
eye
glaucoma
secondari
anterior
uveiti
may
normal
rang
simultan
decreas
aqueou
humor
product
outflow
measur
iop
perform
patient
anterior
uveiti
develop
secondari
glaucoma
suspect
iop
greater
mm
hg
eye
anterior
uveiti
eye
monitor
close
increas
iop
glaucoma
treat
best
carbon
anhydras
inhibitor
betablock
decreas
aqueou
humor
product
carbon
anhydras
inhibitor
administ
oral
dichlorphenamid
mgkg
methazolamid
mgkg
topic
dorzolamid
brinzolamid
system
side
effect
vomit
diarrhea
pant
depress
potassium
deplet
less
like
topic
treatment
timolol
betaxolol
carteolol
levobunolol
metipranolol
topic
betaadrenerg
block
agent
administ
betablock
use
caution
anim
show
sign
heart
failur
bronchial
asthma
potenti
system
absorpt
cataract
may
result
uveiti
especi
chronic
extent
cataract
format
depend
sever
durat
inflamm
may
involv
len
capsul
may
affect
entir
len
len
sublux
complet
luxat
also
occur
result
chronic
uveiti
especi
common
eye
becom
buphthalm
result
glaucoma
remov
cataract
luxat
len
caus
chronic
recurr
anterior
uveiti
usual
reward
uveiti
remain
problem
may
exacerb
surgeri
chorioretin
lead
partial
complet
retin
detach
end
result
chorioretin
degener
affect
retina
irregularli
shape
area
tapet
hyperreflect
often
indic
retin
degener
secondari
previou
inflamm
extens
chorioretin
result
visual
impair
entir
retina
involv
complet
blind
result
retin
degener
